Cargando…
Are eyes the windows to COVID-19? Systematic review and meta-analysis
OBJECTIVE: To review and critically appraise the ocular manifestation and the presence of SARS-CoV-2 through PCR positivity from ocular samples in COVID-19-related patients. Moreover, to evaluate the time and severity association of ocular manifestation to systemic disease of COVID-19. METHODS AND A...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476422/ https://www.ncbi.nlm.nih.gov/pubmed/34192152 http://dx.doi.org/10.1136/bmjophth-2020-000563 |
_version_ | 1783579697860313088 |
---|---|
author | La Distia Nora, Rina Putera, Ikhwanuliman Khalisha, Dhiya Farah Septiana, Indah Ridwan, Asri Salima Sitompul, Ratna |
author_facet | La Distia Nora, Rina Putera, Ikhwanuliman Khalisha, Dhiya Farah Septiana, Indah Ridwan, Asri Salima Sitompul, Ratna |
author_sort | La Distia Nora, Rina |
collection | PubMed |
description | OBJECTIVE: To review and critically appraise the ocular manifestation and the presence of SARS-CoV-2 through PCR positivity from ocular samples in COVID-19-related patients. Moreover, to evaluate the time and severity association of ocular manifestation to systemic disease of COVID-19. METHODS AND ANALYSIS: A systematic literature search from PubMed, ScienceDirect and Google Scholar databases was performed using standardised Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Selected keywords were related to COVID-19, ocular manifestation and PCR testing of SARS-CoV-2. Studies were assessed for their validity, and the data were extracted by two independent reviewers. Observational, case series and case report studies were included if they met the selection criteria. Meta-analysis was performed to estimate the pooled prevalence of ocular manifestations and PCR positivity from tears. RESULTS: Thirty-one articles were qualitatively reviewed, and 14 studies were included in the meta-analysis. The pooled prevalence of ocular manifestation among COVID-19-related patients was 0.05 (95% CI 0.02% to 0.08). The overall PCR from tears samples positivity rate from COVID-19-related patients presenting with ocular manifestation was 0.38 (95% CI 0.14% to 0.65). Ocular manifestation could precede systemic manifestation in about 0.28 (95% CI 0.05% to 0.58) of COVID-19-related patients with ocular manifestations. Besides, ocular manifestation was not associated with a severe form of COVID-19. CONCLUSION: Although the overall number of ocular manifestation and SARS-CoV-2 PCR positivity rate from ocular samples was very low, around a quarter of COVID-19-related patients with ocular manifestation presented their ocular manifestation earlier than the systemic manifestation regardless of the severity. Interestingly, SARS-CoV-2 PCR was positive from one-third of ocular samples, which could potentially be the source of infection to the respiratory tract and the environment, although the infectivity is yet to be determined. |
format | Online Article Text |
id | pubmed-7476422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-74764222020-09-08 Are eyes the windows to COVID-19? Systematic review and meta-analysis La Distia Nora, Rina Putera, Ikhwanuliman Khalisha, Dhiya Farah Septiana, Indah Ridwan, Asri Salima Sitompul, Ratna BMJ Open Ophthalmol Original Research OBJECTIVE: To review and critically appraise the ocular manifestation and the presence of SARS-CoV-2 through PCR positivity from ocular samples in COVID-19-related patients. Moreover, to evaluate the time and severity association of ocular manifestation to systemic disease of COVID-19. METHODS AND ANALYSIS: A systematic literature search from PubMed, ScienceDirect and Google Scholar databases was performed using standardised Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Selected keywords were related to COVID-19, ocular manifestation and PCR testing of SARS-CoV-2. Studies were assessed for their validity, and the data were extracted by two independent reviewers. Observational, case series and case report studies were included if they met the selection criteria. Meta-analysis was performed to estimate the pooled prevalence of ocular manifestations and PCR positivity from tears. RESULTS: Thirty-one articles were qualitatively reviewed, and 14 studies were included in the meta-analysis. The pooled prevalence of ocular manifestation among COVID-19-related patients was 0.05 (95% CI 0.02% to 0.08). The overall PCR from tears samples positivity rate from COVID-19-related patients presenting with ocular manifestation was 0.38 (95% CI 0.14% to 0.65). Ocular manifestation could precede systemic manifestation in about 0.28 (95% CI 0.05% to 0.58) of COVID-19-related patients with ocular manifestations. Besides, ocular manifestation was not associated with a severe form of COVID-19. CONCLUSION: Although the overall number of ocular manifestation and SARS-CoV-2 PCR positivity rate from ocular samples was very low, around a quarter of COVID-19-related patients with ocular manifestation presented their ocular manifestation earlier than the systemic manifestation regardless of the severity. Interestingly, SARS-CoV-2 PCR was positive from one-third of ocular samples, which could potentially be the source of infection to the respiratory tract and the environment, although the infectivity is yet to be determined. BMJ Publishing Group 2020-09-06 /pmc/articles/PMC7476422/ /pubmed/34192152 http://dx.doi.org/10.1136/bmjophth-2020-000563 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Original Research La Distia Nora, Rina Putera, Ikhwanuliman Khalisha, Dhiya Farah Septiana, Indah Ridwan, Asri Salima Sitompul, Ratna Are eyes the windows to COVID-19? Systematic review and meta-analysis |
title | Are eyes the windows to COVID-19? Systematic review and meta-analysis |
title_full | Are eyes the windows to COVID-19? Systematic review and meta-analysis |
title_fullStr | Are eyes the windows to COVID-19? Systematic review and meta-analysis |
title_full_unstemmed | Are eyes the windows to COVID-19? Systematic review and meta-analysis |
title_short | Are eyes the windows to COVID-19? Systematic review and meta-analysis |
title_sort | are eyes the windows to covid-19? systematic review and meta-analysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476422/ https://www.ncbi.nlm.nih.gov/pubmed/34192152 http://dx.doi.org/10.1136/bmjophth-2020-000563 |
work_keys_str_mv | AT ladistianorarina areeyesthewindowstocovid19systematicreviewandmetaanalysis AT puteraikhwanuliman areeyesthewindowstocovid19systematicreviewandmetaanalysis AT khalishadhiyafarah areeyesthewindowstocovid19systematicreviewandmetaanalysis AT septianaindah areeyesthewindowstocovid19systematicreviewandmetaanalysis AT ridwanasrisalima areeyesthewindowstocovid19systematicreviewandmetaanalysis AT sitompulratna areeyesthewindowstocovid19systematicreviewandmetaanalysis |